| Assays for Antiretroviral Resistance: Related Resources |
 |
| Content reviewed April 2009 |
 |
 |
|  | | Related Knowledge Base Chapters | |  |
| Journal Articles | |  |
| Guidelines and Best Practices |  |  | Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2008 Recommendations of an International AIDS Society-USA Panel CID, 2008:47. [PDF, 447] See also Update of the Drug Resistance Mutations in HIV-1: December 2008, Top HIV Med. 2008 Dec;16(5):138-45. |  |  |  | World Health Organization/HIVResNet Drug Resistance Laboratory Strategy Bertagnolio S, Derdelinckx I, Parker M, et al. Antivir Ther. 2008;13 Suppl 2:49-57. April 2008.
A laboratory strategy developed by the WHO and the HIVResNet Laboratory Working Group aimed at assisting countries in the development of protocols, standards, and performance indicators for HIV resistance testing. |  |  |  | Guidance for Industry: Class II Special Controls Guidance Document: In Vitro HIV Drug Resistance Genotype Assay U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Rockville, MD: DHHS; August 2007. |  |
|  |
| Conference Reports and Proceedings | |  |
| Online Books and Chapters | |  |
| Clinician Support Tools | |  |
| Slide Sets | |  |
| Images | |  |
| Patient and Community Education | |  |
| Links | |  |
|